SUPPLEMENTARY INFORMATION
Production and purification of recombinant toxin A chains.
The recombinant PAC and RAC, containing a 6xHis-tag and tobacco etch virus (TEV) cleavage peptide at the N-terminus, were separately expressed in E. coli Rosetta (DE3) as described elsewhere 36 . Recombinant proteins were purified on a 5-ml HisTrap column, eluted by adding increasing concentrations of imidazole, and collected. The 6xHis-tag was removed by TEV protease cleavage, dialyzed, concentrated and purified on a HiPrep 26/60 Sephacryl S-200 column (GE Healthcare). The purified products were analyzed by SDS-PAGE before and after purification by HisTrap Nickel Column, after cleavage by TEV protease, and after purification of His6 tag-removed product by Sephacryl S-200 column (data not shown). Fractions containing purified either PAC or RAC were reduced in 2mM B-mercaptoethanol, pooled, and concentrated to 2 mg/ml and stored at -80°C.
Optimization of LC-SPDP biolinker concentration.
HIV mAb 924 (1 mg) in 0.5 ml PBS, pH 8.0, was mixed separately with 10, 20 and 40-fold molar excess of N-succinimidyl 3-(2-pyridyldithio) propionate with long spacer arm (LC-SPDP) (Pierce Chemical. Rockford. IL). After 2 hr incubation at room temperature, they were passed from Zeba columns equilibrated in PBS.
At the same time, RAC and PAC (1 mg in 0.5 ml) were reduced for 30 min in 50 mM dithiothreitol, then were passed from Zeba columns equilibrated in PBS. The two products, RAC and PAC were mixed separately with 10, 20 or 40-fold molar excess of Antibody-biolinker, concentrated to 0.5 ml and incubated overnight at 4°C. The six individual fractions were analyzed by Microcapillary Electrophoresis and bicinchoninic acid protein assay to find the optimum conjugation. Figure S1 demonstrates that the conjugates with 40-fold molar excess of biolinker can harbor more A chain toxin. 
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